ClinicalTrials.gg
Active, not recruitingNCT07395180Updated Feb 9, 2026

Differentiation of Human Body Balance Disorders

An interventional study of Patients after stroke and Patients with posterior columns of the spinal cord in Stroke, Visual Defects and Labyrinth Diseases, sponsored by Military Institute od Medicine National Research Institute. Active, not recruiting at 1 site in Poland. Open to participants aged 20 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-09.

Sponsored by Military Institute od Medicine National Research Institute · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was expected by Feb 2026, 8 months ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
330
Allocation
Non-randomized
Ages
20 Years to 80 Years
Sex
All
01

Study summary

Our research aims to analyze the possibilities of functional assessment of imbalances in the human body. Using the available, commonly known and used tests and devices for objective examination of static and dynamic body balance, as well as changes in the tension of selected muscles of the cervical spine in static and dynamic conditions, depending on visual control or its absence, we hope to identify important research tools that help to differentiate the causes of imbalances. Studies conducted on a group of healthy people and groups of patients: after a stroke, with changes in the posterior cords of the spinal cord, with labyrinth disorders, with degenerative changes in the spine, with visual impairments, and in healthy people, seem to be important in the analysis of the discussed topic. The investigators will answer the following detailed research questions: 1. Does the type of disease/disease or its absence affect the human balance in the Romberg test? 2. Do visual defects affect the tension of the muscles of the cervical spine? 3. Do changes in the muscle tension of the cervical spine affect the ability to maintain balance in the Unterberger test? 4. Do the mobility deficits in the cervical spine coincide with cervical or labyrinthine balance disorders in the differential test for vertigo and in the Fukuda test? 5. How does the tension of the muscles of the cervical spine change in the tested groups on the stable and unstable, depending on the vision control? 6. Does the type of disease/illness or its absence affect changes in the tension of the muscles of the cervical spine, and does it correlate with the balance of the body on a stable and unstable surface? The results of the research may facilitate the functional differentiation of imbalances in the human body. The investigators hypothesize that functional tests will help determine the cause of imbalance in the human body. This will allow us to determine with high probability the dominant cause of balance disorders (eye disorders, changes in the cervical spine / musculoskeletal system, labyrinth, proprioceptors, cerebellum, posterior cords of the spinal cord), already at the initial stage of diagnosis. The research will improve the process of implementing effective treatment and therapeutic procedures.

02

Conditions studied

  • Stroke
  • Visual Defects
  • Labyrinth Diseases
  • Cervical Spine Degenerative Disease
  • Healthy
  • Posterior Columns of the Spinal Cord

Keywords

  • stroke
  • posterior columns of the spinal cord
  • cervical spine degenerative disease
  • labyrinth diseases
  • visual defects
  • healthy
  • balance
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's planned enrollment of 330 is above the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Military Institute od Medicine National Research Institute is the lead sponsor of 45 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 1) stroke patients (7 to 9 weeks after cerebellar stroke), with degenerative changes of the spine, including the cervical section, with labyrinth disorders, with visual defects, with changes in the posterior cords of the spinal cord;
  • 2) functional status of patients that allows them to stand and walk in place and over a distance (Rankin ≤ 3);
  • 3) Modified Ashworth Muscle Tone Scale (MAS ≤1/1+);
  • 4) positive Tandem test;
  • 5) no major deficits in communication, memory or comprehension which may impede correct measurement;
  • 6) over 20 years of age; maximum 80 years.

The main criteria for inclusion in the control group:

  • 1) healthy people with a stable trunk (100 TCT points);
  • 2) having normal muscle tone (MAS=0), walking independently;
  • 3) at least 20 years old; maximum 80 years.

Exclusion criteria

Exclusion Criteria:

  • 1) coexisting diseases considered in the study;
  • 2) stroke up to seven weeks after the episode;
  • 3) epilepsy;
  • 4) lack of trunk stability;
  • 5) lack of independent standing and walking;
  • 6) high or very low blood pressure, dizziness, malaise.

Criteria for exclusion from the control group:

  • 1) history of neurological or musculoskeletal disorders, such as stroke or brain injury, or other neurological conditions that may affect their ability to move the trunk and legs actively;
  • 2) degenerative changes, labyrinth disorders, vision defects;
  • 3) pain, dizziness;
  • 4) constant use of orthopedic supplies;
  • 5) severe deficits in communication, memory, or comprehension, which may make it difficult to perform the measurement correctly;
  • 6) high or very low blood pressure, feeling unwell.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
330 participants (estimated)

Study arms

  • Experimental
    Patients after stroke

    Diagnostic Test: Patients after stroke · Diagnostic Test: Patients with posterior columns of the spinal cord · Diagnostic Test: Patients with labyrinth diseases · Diagnostic Test: Patients with visual defects · Diagnostic Test: Patients with cervical spine degenerative disease · Diagnostic Test: Healthy participants

  • Experimental
    Patients with posterior columns of the spinal cord

    Diagnostic Test: Patients after stroke · Diagnostic Test: Patients with posterior columns of the spinal cord · Diagnostic Test: Patients with labyrinth diseases · Diagnostic Test: Patients with visual defects · Diagnostic Test: Patients with cervical spine degenerative disease · Diagnostic Test: Healthy participants

  • Experimental
    Patients with labyrinth diseases

    Diagnostic Test: Patients after stroke · Diagnostic Test: Patients with posterior columns of the spinal cord · Diagnostic Test: Patients with labyrinth diseases · Diagnostic Test: Patients with visual defects · Diagnostic Test: Patients with cervical spine degenerative disease · Diagnostic Test: Healthy participants

  • Experimental
    Patients with visual defects

    Diagnostic Test: Patients after stroke · Diagnostic Test: Patients with posterior columns of the spinal cord · Diagnostic Test: Patients with labyrinth diseases · Diagnostic Test: Patients with visual defects · Diagnostic Test: Patients with cervical spine degenerative disease · Diagnostic Test: Healthy participants

  • Experimental
    Patients with cervical spine degenerative disease

    Diagnostic Test: Patients after stroke · Diagnostic Test: Patients with posterior columns of the spinal cord · Diagnostic Test: Patients with labyrinth diseases · Diagnostic Test: Patients with visual defects · Diagnostic Test: Patients with cervical spine degenerative disease · Diagnostic Test: Healthy participants

  • Other
    Healthy participants

    Diagnostic Test: Patients after stroke · Diagnostic Test: Patients with posterior columns of the spinal cord · Diagnostic Test: Patients with labyrinth diseases · Diagnostic Test: Patients with visual defects · Diagnostic Test: Patients with cervical spine degenerative disease · Diagnostic Test: Healthy participants

Interventions

  • Diagnostic testPatients after stroke

    Body posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG.

  • Diagnostic testPatients with posterior columns of the spinal cord

    Body posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG.

  • Diagnostic testPatients with labyrinth diseases

    Body posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG.

  • Diagnostic testPatients with visual defects

    Body posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG.

  • Diagnostic testPatients with cervical spine degenerative disease

    Body posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG.

  • Diagnostic testHealthy participants

    Body posture assessment (APECS), the Tandem test, the Trunk Stability test, the modified Rankin Scale to assess the general physical impairment of patients, and the National Institute for Health Stroke Scale (NIHSS) to determine the neurological deficit. , and the Modified Ashworth Scale, Romberg test, Fukuda test, differential test for vertigo, Unterberg test, body balance test using Biodex SD balance platform, Cervical spine muscle tone test using Luna EMG.

06

What researchers measure

Primary outcomes

  1. Advanced Packaging and Heterogeneous Integration for Electronic Components and Systems (APECS)

    Evaluation of body posture in the frontal and sagittal planes - Advanced Packaging and Heterogeneous Integration for Electronic Components and Systems (APECS)

    Time frame: Day 1

  2. The Tandem Test

    Time frame: Day 1

  3. Modified Ashworth Scale (MAS)

    Time frame: Day 1

  4. Trunk Stability Test

    Time frame: Day 1

  5. Rankin Scale

    Time frame: Day 1

  6. NATIONAL INSTITUTES OF HEALTH STROKE SCALE (NIHSS)

    Time frame: Day 1

Secondary outcomes

  1. Romberg test

    Time frame: Day 1

  2. Fukuda test

    Time frame: Day 1

  3. Differential test for vertigo

    Time frame: Day 1

  4. Body balance test on the Biodex SD platform

    Time frame: Day 1

  5. Cervical spine muscle tone test using Luna EMG

    Time frame: Day 1

  6. Unterberger test

    Time frame: Day 1

07

Study locations

1 site
  • Military Institute od Medicine National Research Institute
    Warsaw, 04-141, Poland
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07395180
Lead sponsor
Military Institute od Medicine National Research Institute
Responsible party
Anna Olczak (PhD; Senior Specialist of the Rehabilitation Clinic, Military Institute od Medicine National Research Institute) — Principal investigator
First posted
Feb 9, 2026
Start date
Jan 19, 2026
Primary completion
Feb 28, 2026 (estimated)
Completion
Mar 30, 2027 (estimated)
Last update
Feb 9, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion